Association of gut microbiota and metabolites with tumor response to immune checkpoint inhibitors in patients with unresectable hepatocellular carcinoma.

被引：5
|
作者：
Lee, Pei-Chang
Wu, Chi-Jung
Hung, Ya-Wen
Lee, Chieh-Ju
Chao, Yee
Hou, Ming-Chih
Kuo, Yu-Lun
Chou, Shih-Hsuan
Huang, Yi-Hsiang
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan
[3] Taipei Vet Gen Hosp, Taipei, Taiwan
[4] Biotools Co Ltd, New Taipei, Taiwan
[5] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Inst Clin Med, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e16165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16165
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
    Lee, Pei-Chang
    Wu, Chi-Jung
    Hung, Ya-Wen
    Lee, Chieh Ju
    Chi, Chen-Ta
    Lee, I-Cheng
    Yu-Lun, Kuo
    Chou, Shih-Hsuan
    Luo, Jiing-Chyuan
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (06)
  • [2] Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
    Abd El Aziz, Mohamed A.
    Facciorusso, Antonio
    Nayfeh, Tarek
    Saadi, Samer
    Elnaggar, Mohamed
    Cotsoglou, Christian
    Sacco, Rodolfo
    VACCINES, 2020, 8 (04) : 1 - 19
  • [3] Liver injury by immune checkpoint inhibitors in patients with hepatocellular carcinoma.
    Personeni, Nicola
    Pressiani, Tiziana
    Capogreco, Antonio
    Dal Buono, Arianna
    D'Alessio, Antonio
    Prete, Maria Giuseppina
    Smiroldo, Valeria
    Bozzarelli, Silvia
    Giordano, Laura
    Aghemo, Alessio
    Santoro, Armando
    Rimassa, Lorenza
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [4] THE ASSOCIATION OF THE GUT MICROBIOTA AND CLINICAL RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH ADVANCED CANCER
    Chiu, Cheng-Hsun
    Tsai, Chih-Yu
    Lin, Yu-Fen
    Chang, John
    Wu, Chiao-En
    Yeh, Yuan-Ming
    Shen, Yung-Chi
    Hou, Ming-Mo
    Hsieh, Jia-Juan
    Chang, John
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A226 - A226
  • [5] A preferable signature of gut microbiota and bile acids predicted better outcomes of unresectable hepatocellular carcinoma to immune checkpoint inhibitors
    Lee, Pei-Chang
    Wu, Chijung
    Hung, Ya-Wen
    Lee, ChiehJu
    Chi, Chen-Ta
    Lee, I-Cheng
    Luo, Jiing-Chyuan
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF HEPATOLOGY, 2022, 77 : S109 - S110
  • [6] Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
    Ponziani, Francesca Romana
    De Luca, Angela
    Picca, Anna
    Marzetti, Emanuele
    Petito, Valentina
    Del Chierico, Federica
    Reddel, Sofia
    Paroni Sterbini, Francesco
    Sanguinetti, Maurizio
    Putignani, Lorenza
    Gasbarrini, Antonio
    Pompili, Maurizio
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (06) : 1492 - 1501
  • [7] Impact of gut microbiota on immune modulation and response to immune checkpoint inhibitors in hepatocellular carcinoma: Insights from human and preclinical models
    Rajapakse, Jayashi
    Shen, S. J.
    Khatiwada, Saroj
    Soo, Jason
    Behary, Jason
    Zekry, Amany
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 53 - 53
  • [8] Alteration of gut microbiota in patients with advanced hepatocellular carcinoma.
    Charoenthanadhol, Thanakorn
    Wirasorn, Kosin
    Sookprasert, Aumkhae
    Chindaprasert, Jarin
    Sanlung, Thanachai
    Watcharenwong, Piyakarn
    Putraveephong, Siraphong
    Phetcharaburanin, Jutarop
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 641 - 641
  • [9] ALTERNATION OF GUT MICROBIOTA IN PATIENTS WITH IMMUNE CHECKPOINT INHIBITORS
    Hirata, Yuki
    Tanaka, Yoshiki
    Numa, Keijiro
    Kawasaki, Yuka
    Kinoshita, Naohiko
    Koshiba, Ryoji
    Sakiyama, Naokuni
    Kakimoto, Kazuki
    Takeuchi, Toshihisa
    Miyazaki, Takako
    Nakamura, Shiro
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2022, 162 (07) : S1001 - S1001
  • [10] Comparison of immune checkpoint inhibitor monotherapy versus Sorafenib in unresectable hepatocellular carcinoma.
    Chan, Abigail Sy
    Rout, Amit
    Kumar, Rohit
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16160 - E16160
12345